Variant report
Variant | nsv977238 |
---|---|
Chromosome Location | chr13:50745758-50747910 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:30)
- CpG islands (count:244)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:30 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr13:50747311-50747549 | Hela-S3 | cervix: | n/a | chr13:50747380-50747391 |
2 | CEBPB | chr13:50747203-50747545 | H1-hESC | embryonic stem cell: | n/a | chr13:50747380-50747391 |
3 | CEBPB | chr13:50747199-50747559 | IMR90 | lung: | n/a | chr13:50747380-50747391 |
4 | CEBPB | chr13:50747209-50747551 | K562 | blood: | n/a | chr13:50747380-50747391 |
5 | CEBPB | chr13:50747205-50747560 | A549 | lung: | n/a | chr13:50747380-50747391 |
6 | CEBPB | chr13:50747192-50747500 | K562 | blood: | n/a | chr13:50747380-50747391 |
7 | CEBPB | chr13:50747209-50747565 | HepG2 | liver: | n/a | chr13:50747380-50747391 |
8 | CEBPB | chr13:50747322-50747425 | HepG2 | liver: | n/a | chr13:50747380-50747391 |
9 | EP300 | chr13:50746938-50747194 | GM12878 | blood: | n/a | n/a |
10 | FOSL2 | chr13:50746915-50747480 | HepG2 | liver: | n/a | n/a |
11 | HEY1 | chr13:50746007-50746383 | HepG2 | liver: | n/a | n/a |
12 | JUND | chr13:50747053-50747270 | HepG2 | liver: | n/a | n/a |
13 | POLR2A | chr13:50746112-50746281 | GM12878 | blood: | n/a | n/a |
14 | POLR2A | chr13:50746092-50746299 | A549 | lung: | n/a | n/a |
15 | POLR2A | chr13:50746009-50746385 | H1-hESC | embryonic stem cell: | n/a | n/a |
16 | POLR2A | chr13:50746077-50746319 | Hela-S3 | cervix: | n/a | n/a |
17 | POLR2A | chr13:50746116-50746261 | A549 | lung: | n/a | n/a |
18 | POLR2A | chr13:50746106-50746297 | HepG2 | liver: | n/a | n/a |
19 | POLR2A | chr13:50746713-50747332 | H1-hESC | embryonic stem cell: | n/a | n/a |
20 | POLR2A | chr13:50746122-50746246 | A549 | lung: | n/a | n/a |
21 | POLR2A | chr13:50746110-50746297 | GM12878 | blood: | n/a | n/a |
22 | REST | chr13:50746861-50747300 | H1-hESC | embryonic stem cell: | n/a | n/a |
23 | REST | chr13:50746861-50747284 | H1-hESC | embryonic stem cell: | n/a | n/a |
24 | RXRA | chr13:50746926-50747253 | HepG2 | liver: | n/a | n/a |
25 | SP1 | chr13:50746890-50747553 | HepG2 | liver: | n/a | n/a |
26 | STAT3 | chr13:50747889-50748173 | MCF10A-Er-Src | breast: | n/a | n/a |
27 | TEAD4 | chr13:50746873-50747364 | H1-hESC | embryonic stem cell: | n/a | n/a |
28 | TEAD4 | chr13:50746852-50747302 | HepG2 | liver: | n/a | n/a |
29 | TEAD4 | chr13:50745819-50746091 | H1-hESC | embryonic stem cell: | n/a | n/a |
30 | TEAD4 | chr13:50746886-50747360 | H1-hESC | embryonic stem cell: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr13:50746150-50746200 | AG04450 | lung: | fetal |
2 | chr13:50746150-50746200 | HRPEpiC | eye: | n/a |
3 | chr13:50746138-50746188 | IMR90 | lung: | fetal |
4 | chr13:50746150-50746200 | RPTEC | kidney: | n/a |
5 | chr13:50746150-50746200 | GM19239 | blood: | n/a |
6 | chr13:50746245-50746295 | AG09319 | gingival: | n/a |
7 | chr13:50746150-50746200 | HCF | heart: | n/a |
8 | chr13:50746138-50746188 | SKMC | muscle: | n/a |
9 | chr13:50746150-50746200 | HCT-116 | colon: | n/a |
10 | chr13:50746150-50746200 | PrEC | prostate: | n/a |
11 | chr13:50745832-50745882 | NHDF-neo | bronchial: | n/a |
12 | chr13:50746150-50746200 | ovcar-3 | ovarian: | n/a |
13 | chr13:50746245-50746295 | ProgFib | skin: | n/a |
14 | chr13:50746245-50746295 | MCF-7 | breast: | n/a |
15 | chr13:50746150-50746200 | HepG2 | liver: | n/a |
16 | chr13:50746245-50746295 | Jurkat | blood: | n/a |
17 | chr13:50745832-50745882 | HRE | kidney: | n/a |
18 | chr13:50746150-50746200 | PANC-1 | pancreas: | n/a |
19 | chr13:50745832-50745882 | HCF | heart: | n/a |
20 | chr13:50745832-50745882 | ECC-1 | luminal epithelium: | n/a |
21 | chr13:50746245-50746295 | HRCEpiC | kidney: | n/a |
22 | chr13:50746245-50746295 | GM12891 | blood: | n/a |
23 | chr13:50745832-50745882 | MCF10A-Er-Src | breast: | n/a |
24 | chr13:50745832-50745882 | LNCaP | prostate: | n/a |
25 | chr13:50746245-50746295 | Caco-2 | colon: | n/a |
26 | chr13:50746150-50746200 | SK-N-SH | brain: | n/a |
27 | chr13:50746245-50746295 | NHDF-neo | bronchial: | n/a |
28 | chr13:50746150-50746200 | IMR90 | lung: | fetal |
29 | chr13:50746138-50746188 | HUVEC | blood vessel: | n/a |
30 | chr13:50745832-50745882 | HNPCEpiC | eye: | n/a |
31 | chr13:50746138-50746188 | A549 | lung: | n/a |
32 | chr13:50746150-50746200 | LNCaP | prostate: | n/a |
33 | chr13:50745832-50745882 | GM06990 | blood: | n/a |
34 | chr13:50745832-50745882 | CMK | blood: | n/a |
35 | chr13:50746245-50746295 | HCF | heart: | n/a |
36 | chr13:50745832-50745882 | HRCEpiC | kidney: | n/a |
37 | chr13:50746138-50746188 | HCM | heart: | n/a |
38 | chr13:50746138-50746188 | Hela-S3 | cervix: | n/a |
39 | chr13:50746138-50746188 | HAEpiC | amniotic membrane: | n/a |
40 | chr13:50746245-50746295 | HPAEpiC | pulmonary alveolar: | n/a |
41 | chr13:50746138-50746188 | HPAEpiC | pulmonary alveolar: | n/a |
42 | chr13:50745832-50745882 | HIPEpiC | eye: | n/a |
43 | chr13:50746245-50746295 | AG04449 | skin: | fetal |
44 | chr13:50746150-50746200 | GM06990 | blood: | n/a |
45 | chr13:50745832-50745882 | HepG2 | liver: | n/a |
46 | chr13:50745832-50745882 | PFSK-1 | brain: | n/a |
47 | chr13:50746150-50746200 | Jurkat | blood: | n/a |
48 | chr13:50746150-50746200 | GM12891 | blood: | n/a |
49 | chr13:50745832-50745882 | U87 | brain: | n/a |
50 | chr13:50746138-50746188 | GM06990 | blood: | n/a |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ST13P4 | TF binding region |
ST13P4 | CpG island |
ENSG00000231607 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs538842003 | chr13:50745783-50745784 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs186067968 | chr13:50745785-50745786 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs565656035 | chr13:50745792-50745793 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs536654152 | chr13:50745832-50745833 | Weak transcription Enhancers | TF binding regionCpG island | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs536372310 | chr13:50745833-50745834 | Weak transcription Enhancers | TF binding regionCpG island | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs556245693 | chr13:50745866-50745867 | Weak transcription Enhancers | TF binding regionCpG island | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs151175376 | chr13:50745894-50745895 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs140045863 | chr13:50745903-50745904 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs538144094 | chr13:50745913-50745914 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs574978299 | chr13:50745919-50745920 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs190233137 | chr13:50745966-50745967 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs7333147 | chr13:50745971-50745972 | Weak transcription Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs371725937 | chr13:50746014-50746015 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs545211805 | chr13:50746035-50746036 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs150299665 | chr13:50746115-50746116 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs572427500 | chr13:50746161-50746162 | Weak transcription Enhancers | TF binding regionCpG island | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs112713819 | chr13:50746180-50746181 | Weak transcription Enhancers | TF binding regionCpG island | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs543143025 | chr13:50746198-50746199 | Weak transcription Enhancers | TF binding regionCpG island | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs561116467 | chr13:50746201-50746202 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs531786878 | chr13:50746206-50746207 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs543696518 | chr13:50746216-50746217 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs565191325 | chr13:50746230-50746231 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs532313397 | chr13:50746234-50746235 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs182826091 | chr13:50746235-50746236 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs565899592 | chr13:50746252-50746253 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs137951209 | chr13:50746310-50746311 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs3070815 | chr13:50746345-50746346 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs116067924 | chr13:50746351-50746352 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs569503286 | chr13:50746384-50746385 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs536656867 | chr13:50746398-50746399 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs3070818 | chr13:50746404-50746405 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs556404281 | chr13:50746428-50746429 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs142249789 | chr13:50746436-50746437 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs538976495 | chr13:50746441-50746442 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs554058843 | chr13:50746452-50746453 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs200448472 | chr13:50746496-50746497 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs542752850 | chr13:50746509-50746510 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs555050427 | chr13:50746524-50746525 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs3990243 | chr13:50746533-50746534 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs3990244 | chr13:50746540-50746541 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs576467700 | chr13:50746607-50746608 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs3958732 | chr13:50746617-50746618 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs3990245 | chr13:50746623-50746624 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs3990246 | chr13:50746629-50746630 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs187390514 | chr13:50746646-50746647 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs192174178 | chr13:50746649-50746650 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs183749794 | chr13:50746717-50746718 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs532430285 | chr13:50746889-50746890 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs541355670 | chr13:50746930-50746931 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs530631275 | chr13:50746931-50746932 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 17899364 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17133270 | CNVD |
Myoepithelioma | 18604193 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Trisomy | 24170809 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Alveolar rhabdomyosarcoma | 16790082 | CNVD |
Prostate cancer | 16573809 | CNVD |
Prostate cancer | 18632612 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Prostate cancer | 19242612 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Prostate cancer | 17245344 | CNVD |
Colorectal cancer | 21586687 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Developmental delay | 21147756 | CNVD |
Melanoma | 18172304 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Chronic lymphocytic leukemia | 17805327 | CNVD |
Mental retardation | 17502991 | CNVD |
Retinoblastoma | 17502991 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Liposarcoma | 21253554 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Cervical cancer | 21062161 | CNVD |
microdeletion syndrome | 19284877 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Chronic lymphocytic leukemia | 17053054 | CNVD |
Multiple myeloma | 19135901 | CNVD |
Autism | 18414403 | CNVD |
Neurocytoma | 17123091 | CNVD |
Central neurocytomas | 17123091 | CNVD |
Prostate cancer | 16461572 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Glioblastoma multiforme | 19435819 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20467480 | CNVD |
Breast cancer | 21858162 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Acute myeloid leukemia | 17237825 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Hereditary prostate cancer | 22028916 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Chronic lymphocytic leukemia | 21049055 | CNVD |
Prostate cancer | 17217626 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16272173 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Breast cancer | 21990379 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:50735600-50745800 | Weak transcription | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
2 | chr13:50741600-50749000 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
3 | chr13:50745600-50746200 | Enhancers | Fetal Heart | heart |
4 | chr13:50745800-50746000 | Enhancers | Osteobl | bone |
5 | chr13:50745800-50746400 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
6 | chr13:50746200-50746800 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |